Based on the catalog of GO terms, the significant enrichment analysis of pathways included hsa05200(pathways in cancer), hsa04010(MAPK signaling pathway), hsa04060(Cytokine-cytokine receptor interaction), hsa04657(IL-17 signaling pathway), hsa04115(p53 signaling pathway), hsa04630 (Jak-STAT signaling pathway), hsa04660(T cell receptor signaling pathway), hsa04659(Th17 cell differentiation), hsa04152(AMPK signaling pathway), hsa04370(VEGF signaling pathway). The gene discussed is IL17A; the disease is cancer.